Members of the Association for Clinical Oncology (ASCO) were on Capitol Hill on April 8, 2025, for the 10th annual ASCO Advocacy Summit, where they met with lawmakers to discuss critical issues in ...

Two topics critical to the future of cancer care and research—and central to ASCO's mission—were the focus of a pair of oncology podcasts that dropped in April. The NRG Oncology podcast, released on ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers ...

Nearly 180 oncology professionals will hold over 240 meetings with Members of Congress and staff on Tuesday, April 8, to advocate for cancer care and research priorities and to provide insight on how ...

The U.S. Supreme Court issued an opinion on Wednesday, April 2, that the Food and Drug Administration (FDA) was within its power to regulate the sale of certain flavored e-cigarette products. The case ...

Sunitinib as first-line therapy (188) 6.7 (5.0-8.9) 7.1 (6.1-9.1) 7.0 (5.4-8.8) ...

Start planning before you arrive at McCormick Place. View the information below so you know where to go for all of your needs while you’re at the Meeting, including onsite childcare and accessibility ...

Explore resources for getting to Chicago and navigating the ASCO Annual Meeting online and in-person.

Please review the following abstract policies when preparing your submission. You can also review the Abstract Policy FAQs page for answers to common questions asked by submitters.

Faculty, Poster Presenters, and Rapid Oral Presenters deadline to submit their presentation materials (slide decks, posters) on ASCO's Speaker Center Website ...

Learn more about abstract submission, policies, and guidelines for faculty and presenters.